Skip to main content
logo
Corvus Pharmaceuticals, Inc. (CRVS)
NASDAQ: CRVS · Real-Time Price · USD
13.31
+0.39 (3.02%)
At close: Jul 28, 2026, 4:00 PM EDT
13.05
-0.26 (-1.95%)
After-hours: Jul 28, 2026, 7:03 PM EDT

Corvus Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
1,1195753638640112
Market Cap Growth
208.16%58.33%320.89%118.11%-64.73%11.08%
Enterprise Value
883.36519.35312.4260.53-0.1346.39
Last Close Price
13.317.705.351.760.852.41

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
4.659.4011.152.230.711.15
P/TBV Ratio
4.6110.0310.022.190.711.04

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/EBITDA Ratio
----0.00-
EV/EBIT Ratio
----0.00-
EV/FCF Ratio
----0.00-

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.000.010.0300.020.03
Net Debt / Equity Ratio
-0.98-0.91-1.56-0.67-0.71-0.68
Net Debt / EBITDA Ratio
4.931.301.851.111.231.72
Net Debt / FCF Ratio
6.711.692.001.081.461.79
Quick Ratio
19.556.051.473.963.997.22
Current Ratio
19.816.211.544.074.067.36
Return on Equity (ROE)
-29.26%-32.60%-174.85%-57.02%-53.90%-51.08%
Return on Assets (ROA)
-29.56%-61.38%-48.14%-41.14%-36.65%-39.62%
Return on Invested Capital (ROIC)
-355.20%-307.01%-163.70%-104.55%-100.21%-96.02%
Return on Capital Employed (ROCE)
-31.65%-90.23%-76.32%-48.68%-41.42%-44.62%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Buyback Yield / Dilution
-24.98%-30.76%-26.99%-3.16%-11.23%-41.98%
Total Shareholder Return
-24.98%-30.76%-26.99%-3.16%-11.23%-41.98%
SEC Filings: 10-K · 10-Q